The notices it replaced
- Reissues: PA-18-576 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
Replaced by PA-20-261.
Who won it before
29 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,286,859 in first-year total cost, median $349,024.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]6
- Special Emphasis Panel[ZRG1 MOSS-V (15)]3
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]3
- Special Emphasis Panel[ZRG1 ETTN-G (12)]2
- Special Emphasis Panel[ZRG1 OTC-R (11)]2
Most frequent institutions
- INHERET, INC2
- PRAXIS, INC.2
- ACTINIUM PHARMACEUTICALS, INC.1
- ARBOR GRACE, INC.1
- ASCENDING HEARING TECHNOLOGIES, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Family Supportive Supervisor Training and Workplace Assessment Tool2R42AG050347-02A1 | KOSSEK, ELLEN ERNST | WORK LIFE HELP, INC., MI | $471,990 | ZRG1 |
| 2021 | Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma1R42CA257797-01 | SHOKEEN, MONICA | SARYA, LLC, MO | $398,858 | ZRG1 |
| 2021 | PRANAYAMA BASED GROUP VIDEO APP FOR CANCER SURVIVORSHIP. Phase I. Breast Cancer Pilot1R41CA254557-01A1 | BALASUBRAMANIAN, SUNDARAVADIVEL | PRANASCIENCE INSTITUTE LLC, SC | $388,724 | ZRG1 |
| 2021 | Disseminable Evidence-Based Treatment for the Dental Office: Virtual Exposure Tools for Dental Fear - neVR Fear the Dentist1R42DE030040-01 | ADAMS LARSEN, MARGOHEYMAN, RICHARD ELIOTSLEP, AMY MICHELE SMITH | VIRTUALLY BETTER, INC., GA | $264,997 | ZRG1 |
| 2020 | Personalized dosing of dichloroacetate for the treatment of rare and common diseases2R42HD089804-04 | STACPOOLE, PETER WALLACE | MEDOSOME BIOTEC, LLC, FL | $1,000,000 | ZRG1 |
| 2020 | InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.2R42CA239842-02A1 | KEREN, DAVID FREEMAN | INHERET, INC, MI | $993,562 | ZRG1 |
| 2020 | Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL1R42CA254685-01 | BERGER, MARK SGEYER, MARK B | ACTINIUM PHARMACEUTICALS, INC., NY | $378,389 | ZRG1 |
| 2020 | Clinical feasibility of a non-invasive, low-cost wearable for measuring air trapping in COPD1R41HL152769-01A1 | ARTUNDUAGA, MARIA | SAMAY, INC., CA | $350,000 | ZRG1 |
| 2020 | Non-Invasive Imaging of Oral Cavity Cancer1R42CA254776-01A1 | BRAND, CHRISTIANPATEL, SNEHALREINER, THOMAS | SUMMIT BIOMEDICAL IMAGING, LLC, NY | $262,732 | ZRG1 |
| 2020 | FES-Rowing: Preventing the Secondary Conditions of Paralysis Through Vigorous Exercise1R41HD102267-01A1 | BELLMAN, MATTHEW JOHNTAYLOR, J ANDREW | MYOLYN, LLC, FL | $212,235 | ZRG1 |
| 2019 | Clinical validation and commercialization of a novel hydrogel-based vaginal packing system for pelvic brachytherapy2R42CA203171-02A1 · under PA-18-576 | SHOWALTER, TIMOTHY NORMAN | BRACHYFOAM, LLC, VA | $770,412 | ZRG1 |
| 2019 | Automated point-of-care identification of innocent Still's murmur in children2R42HL131081-02 · under PA-18-576 | DOROSHOW, ROBINSHEKHAR, RAJ | AUSCULTECH DX, LLC, MD | $764,643 | ZRG1 |
| 2019 | MISSION U: A MULTIMEDIA TRAINING TOOL FOR TREATING INDIVIDUALS WITH CO-OCCURRING MENTAL HEALTH AND SUBSTANCE USE DISORDERS2R42AA026751-02 · under PA-18-576 | SMELSON, DAVID A | PRAXIS, INC., MA | $751,223 | ZRG1 |
| 2019 | Online Training For Addressing Perinatal Depression2R42MH113381-02 · under PA-18-576 | BYATT, NANCYMOORE SIMAS, TIFFANY ANNE | PRAXIS, INC., MA | $746,903 | ZRG1 |
| 2019 | Continuing Care App for Probationers and Parolees with Substance Use Disorders2R44MD008848-02 · under PA-18-576 | CARSWELL, STEVEN BERNARDGORDON, MICHAEL SCOTT | COG ANALYTICS, LLC, MD | $546,245 | ZRG1 |
| 2019 | Evolution of an Adaptable Prosthetic Foot Design for Normalization of Biomechanics During Community Participation2R42HD093476-02A1 · under PA-18-576 | COLVIN, JAMES | OHIO WILLOW WOOD COMPANY, OH | $449,359 | ZRG1 |
| 2019 | High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators1R41HG010638-01 · under PA-18-576 | LYNCH, KRISTEN WYEAKLEY, JOANNE MULLIGAN | BIOSPYDER TECHNOLOGIES, INC., CA | $349,024 | ZRG1 |
| 2019 | InheRET: A SaaS solution to identifying patients at increased risk for hereditary disease1R41CA239842-01 · under PA-18-576 | KEREN, DAVID FREEMAN | INHERET, INC, MI | $299,828 | ZRG1 |
| 2019 | Increasing Access and Developing Predictors for Colorectal Cancer Screening for Minority and Medicaid Clients1R41CA232824-01A1 · under PA-18-576 | ERWIN, DEBORAH OJOHNSON, DEE D | WITNESS CARES, LLC, NY | $296,546 | ZRG1 |
| 2019 | Custom-Fit Personal Sound Amplification Smartphone Application1R41DC017939-01 · under PA-18-576 | RUNGE, CHRISTINA L | ASCENDING HEARING TECHNOLOGIES, LLC, WI | $263,677 | ZRG1 |
| 2019 | Development of a Neonatal Jaundice Treatment Accelerator by Circumferential Redirection of Unused Phototherapy Light onto the Infants Untreated Skin Surface1R41HD093478-01A1 · under PA-18-576 | SLUSHER, TINA MARYE | ARBOR GRACE, INC., MI | $229,235 | ZRG1 |
| 2019 | Me & You-Tech: A socio-ecological solution to teen dating violence for the digital age.1R42HD100233-01 · under PA-18-576 | MCLAUGHLIN, JEFFERYPESKIN, MELISSASHEGOG, ROSS | RADIANT CREATIVE GROUP, LLC, TX | $225,000 | ZRG1 |
| 2019 | Culturally sensitive, evidence-based, Spanish language mobile app for smoking cessation for Latino cigarette smokers1R41DA048692-01 · under PA-18-576 | BROWN, RICHARD AZVOLENSKY, MICHAEL J. | HEALTH BEHAVIOR SOLUTIONS, INC., TX | $224,989 | ZRG1 |
| 2019 | Mitigation of Radiation Therapy Induced Neuroinflammation and Cognitive Dysfunction1R42CA236382-01 · under PA-18-576 | SREDNI, SIMONE TREIGERWINDISCH, MANFRED | IMMUNOCHEM THERAPEUTICS, LLC, MA | $224,888 | ZRG1 |
| 2019 | The Point Digit: A ratcheting prosthetic finger using advanced rapid manufacturing technology1R42HD097827-01A1 · under PA-18-576 | WEIR, RICHARD FERGUS FFRENCH | POINT DESIGNS, LLC, CO | $224,150 | ZRG1 |
| 2019 | MoodRing: A multi-stakeholder platform to monitor and manage adolescents' depression in primary care with passive mobile sensing.1R44MH122067-01 · under PA-18-576 | DORYAB, AFSANEHRADOVIC-STAKIC, ANASHAABAN, SAMI | NURELM E-BUSINESS SOFTWARE, PA | $223,419 | ZRG1 |
| 2018 | Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care2R42HD088325-02A1 · under PA-18-576 | ARONSON, IAN DAVID | DIGITAL HEALTH EMPOWERMENT, INC., NY | $477,293 | ZRG1 |
| 2018 | Making Standing Balance The Fifth Vital Sign in Clinical Settings1R42AG062065-01 · under PA-18-576 | BERME, NECIP | BERTEC CORPORATION, OH | $275,801 | ZRG1 |
| 2018 | Surefooted Fall Simulation Training1R41AG057285-01A1 · under PA-18-576 | JAYAKUMAR, UDAI | SUREFOOTED, LLC, IL | $222,737 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.